Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maher

Showing results (1121-1130 of 1,158) with videos related to

Pageof 116
Sort By:
Lancet (London, England)|December 20, 2015
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trialJohan A Maertens, Issam I Raad, Kieren A Marr, et al.
The Lancet. Respiratory Medicine|August 19, 2022
Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association studyRichard J Allen, Justin M Oldham, David A Jenkins, et al.
The Lancet. Rheumatology|January 24, 2024
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statementsAnna-Maria Hoffmann-Vold, Toby M Maher, Edward E Philpot, et al.
American Journal of Medical Genetics. Part A|January 5, 2011
Genotype-phenotype analysis of the branchio-oculo-facial syndromeJeff M Milunsky, Tom M Maher, Geping Zhao, et al.
Science Translational Medicine|September 28, 2018
PD-1 up-regulation on CD4<sup>+</sup> T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 productionLindsay J Celada, Jonathan A Kropski, Jose D Herazo-Maya, et al.
American Journal of Respiratory and Critical Care Medicine|June 27, 2019
Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary FibrosisSimon L F Walsh, David J Lederer, Christopher J Ryerson, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|June 13, 2024
The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseasesFederica Genovese, Cecilie Bager, Peder Frederiksen, et al.
The European Respiratory Journal|September 2, 2017
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort studySimon L F Walsh, Toby M Maher, Martin Kolb, et al.
Acta Neuropathologica|August 2, 2025
PLAG1 fusions define a third subtype of CNS embryonal tumor with PLAG family gene alterationMichaela-Kristina Keck, Maysa Al-Hussaini, Nisreen Amayiri, et al.
American Journal of Respiratory and Critical Care Medicine|December 19, 2023
Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop ReportSydney B Montesi, Christian R Gomez, Michael Beers, et al.
Pageof 116

Showing results (1121-1130 of 1,158) with videos related to

Sort By:
Pageof 116
Lancet (London, England)|December 20, 2015
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trialJohan A Maertens, Issam I Raad, Kieren A Marr, et al.
The Lancet. Respiratory Medicine|August 19, 2022
Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association studyRichard J Allen, Justin M Oldham, David A Jenkins, et al.
The Lancet. Rheumatology|January 24, 2024
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statementsAnna-Maria Hoffmann-Vold, Toby M Maher, Edward E Philpot, et al.
American Journal of Medical Genetics. Part A|January 5, 2011
Genotype-phenotype analysis of the branchio-oculo-facial syndromeJeff M Milunsky, Tom M Maher, Geping Zhao, et al.
Science Translational Medicine|September 28, 2018
PD-1 up-regulation on CD4<sup>+</sup> T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 productionLindsay J Celada, Jonathan A Kropski, Jose D Herazo-Maya, et al.
American Journal of Respiratory and Critical Care Medicine|June 27, 2019
Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary FibrosisSimon L F Walsh, David J Lederer, Christopher J Ryerson, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|June 13, 2024
The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseasesFederica Genovese, Cecilie Bager, Peder Frederiksen, et al.
The European Respiratory Journal|September 2, 2017
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort studySimon L F Walsh, Toby M Maher, Martin Kolb, et al.
Acta Neuropathologica|August 2, 2025
PLAG1 fusions define a third subtype of CNS embryonal tumor with PLAG family gene alterationMichaela-Kristina Keck, Maysa Al-Hussaini, Nisreen Amayiri, et al.
American Journal of Respiratory and Critical Care Medicine|December 19, 2023
Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop ReportSydney B Montesi, Christian R Gomez, Michael Beers, et al.
Pageof 116